First Online: 23 December 2016
: J.A.D. is employed by the Howard Hughes Medical Institute (HHMI) and works at the University at California (UC), Berkeley, USA. UC Berkeley and HHMI have patents pending for CRISPR technologies on which J.A.D. and J.E.C. are inventors. J.A.D. is the executive director and J.E.C is the scientific director of the Innovative Genomics Initiative (IGI) at UC Berkeley and University of California, San Francisco. J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences, and a scientific adviser to Caribou, Intellia, eFFECTOR Therapeutics and Driver. J.E.C. is a consultant to or has funded research collaborations with AstraZeneca, CRISPR Therapeutics, Editas Medicine, Genentech, Intellia and Pfizer.